Related Experiment Videos
Schizophrenia costs and treatment cost-effectiveness
1Personal Social Services Research Unit, London School of Economics and Political Science and Centre for the Economics of Mental Health, Institute of Psychiatry, King's College, UK.
Acta Psychiatrica Scandinavica. Supplementum
|March 23, 2001
Summary
Schizophrenia incurs substantial costs across society. However, specific interventions like counseling, family support, and atypical antipsychotics are effective and cost-effective treatments.
Area of Science:
- Health Economics
- Psychiatry
- Public Health
Background:
- Schizophrenia presents significant economic burdens.
- Understanding treatment costs and effectiveness is crucial for resource allocation.
Purpose of the Study:
- To summarize evidence on the economic costs associated with schizophrenia.
- To evaluate the cost-effectiveness of key treatment modalities for schizophrenia.
Main Methods:
- Systematic reviews and meta-analyses were utilized.
- Examination of published and unpublished evidence from multiple countries.
Main Results:
- Schizophrenia incurs high and broad-ranging costs affecting healthcare, public sectors, families, and individuals.
- Interventions including medication adherence counseling, family interventions (reducing expressed emotion), and atypical antipsychotic drugs demonstrate both effectiveness and cost-effectiveness.
Conclusions:
- Economic evaluations are increasingly vital in mental health treatment decisions due to resource constraints.
- Available evidence supports incorporating cost-effectiveness data into mental health policy and practice.